Nuo Therapeutics, Inc. (AURX) Net margin 2017–2025
Nuo Therapeutics, Inc. (AURX) net profit margin by fiscal year — reported net income divided by reported revenue.
-75.8%FY2025 · since FY2017: -2077.4% → -75.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -75.8% | +94.4 pp |
| FY2024 | -170.2% | +351.0 pp |
| FY2023 | -521.2% | +2304.4 pp |
| FY2022 | -2825.6% | — |
| FY2019 | -817.4% | -704.9 pp |
| FY2018 | -112.5% | +1964.9 pp |
| FY2017 | -2077.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice